Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial update evaluating pyrotinib in combination with vinorelbine for HER2-positive locally advanced or metastatic breast…
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: HER2-positive Breast Cancer Project Initiated by Investigators [Phase 2]
Investigator-initiated Phase 2 clinical trial update for HER2-positive breast cancer involving Fudan University.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab [Phase 3]
Phase 3 trial investigating rechallenge with pyro tinib in HER2-positive metastatic breast cancer previously treated with pyrotinib and tras…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer [Phase 1]
Phase 1 trial investigating eribulin mesylate and everolimus in triple-negative metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) [Phase 3]
Phase 3 trial comparing ABX plus cisplatin to gemcitabine plus cisplatin in triple-negative breast cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow [Phase 2]
Phase 2 clinical trial update investigating secondary adjuvant treatment for patients with isolated tumor cells in bone marrow in breast can…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer [Phase 3]
A phase 3 trial comparing the combination of TC plus Bevacizumab to TC alone and to TAC in women with node-positive or high-risk node-negati…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis [Phase 3]
A Phase 3 trial evaluated adding mirtazapine to dexamethasone and aprepitant for delayed emesis in breast cancer patients; the study has com…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer [Phase 2]
Phase 2 trial update on palbociclib with ovarian suppression and letrozole as neoadjuvant treatment for breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Metronomic PLD in Patients With Primary Endocrine Resistant ABC [Phase 2]
Phase 2 clinical trial update for metronomic pegylated liposomal doxorubicin (PLD) in patients with primary endocrine-resistant advanced bre…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Platinum Rechallenge in Patients With Platinum-sensitive mTNBC [Phase 2]
Phase 2 clinical trial evaluating platinum rechallenge in patients with platinum-sensitive metastatic triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: ImmunoBreast - A Phase Ib Study [Phase 1, Phase 2]
Phase I/II clinical trial update for ImmunoBreast in breast cancer, including triple-negative and metastatic disease, with unspecified statu…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Carboplatin in Triple Negative Breast Cancer (TNBC) [Phase 2]
Phase 2 trial comparing gemcitabine plus cisplatin vs gemcitabine plus carboplatin in triple-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: DP303c in Patients With HER2-positive Unresectable Locally Advanced, Relapsed, or Metastaticbreast Cancer [Phase 2]
Phase 2 trial update for DP303c in HER2-positive unresectable locally advanced, relapsed, or metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: The HeartSpare Plus 1B Trial [Phase 2]
Phase 2 trial update for HeartSpare Plus 1B in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: Ramosetron on Late PONV (Postoperative Nausea and Vomiting) [Phase 4]
Phase 4 trial update on Ramosetron for postoperative nausea and vomiting in female breast cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM Pathway [Phase 2]
Phase 2 clinical trial update for RC48-ADC targeting HER2-expressing metastatic breast cancer with PAM pathway activation.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of F16IL2 with paclitaxel in solid tumors, including breast cancer, completed.
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer [Phase 2]
Phase 2 trial evaluating neratinib with or without fulvestrant in metastatic HER2 non-amplified but HER2-mutant breast cancer has completed …
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer [Phase 2]
Phase 2 study of SPI-2012 or Pegfilgrastim for managing neutropenia in breast cancer has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer [Phase 3]
Phase 3 trial comparing docetaxel and cyclophosphamide to anthracycline-based chemotherapy in HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer [Phase 4]
Phase 4 trial update comparing AC vs TC in HR-positive, HER2-negative early breast cancer; status and results are currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: PALbociclib CoLlaborative Adjuvant Study [Phase 3]
Phase 3 trial evaluating palbociclib as adjuvant therapy for breast cancer is not currently recruiting, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy [Phase 2]
Phase 2 clinical trial update for HR-positive, HER2-negative advanced breast cancer after progression on endocrine therapy.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating pyrotinib maleate combined with vinorelbine for HER2-positive advanced breast cancer has completed.